BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9405727)

  • 41. Reliability of vertebral fractures assessment (VFA) in children with osteogenesis imperfecta.
    Diacinti D; Pisani D; D'Avanzo M; Celli M; Zambrano A; Stoppo M; Diacinti D; Roggini M; Todde F; D'Eufemia P; Pepe J; Minisola S
    Calcif Tissue Int; 2015 Apr; 96(4):307-12. PubMed ID: 25694358
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vertebral fracture assessment (VFA) for monitoring vertebral reshaping in children and adolescents with osteogenesis imperfecta treated with intravenous neridronate.
    Diacinti D; Pisani D; Cipriani C; Celli M; Zambrano A; Diacinti D; Kripa E; Iannacone A; Colangelo L; Nieddu L; Pepe J; Minisola S
    Bone; 2021 Feb; 143():115608. PubMed ID: 32829035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta.
    Wekre LL; Eriksen EF; Falch JA
    Arch Osteoporos; 2011; 6(1):31-8. PubMed ID: 22207876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional significance of bone density measurements in children with osteogenesis imperfecta.
    Huang RP; Ambrose CG; Sullivan E; Haynes RJ
    J Bone Joint Surg Am; 2006 Jun; 88(6):1324-30. PubMed ID: 16757767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone mineral density of the lumbar vertebrae in children and adolescents with insulin-dependent diabetes mellitus.
    Ponder SW; McCormick DP; Fawcett HD; Tran AD; Ogelsby GW; Brouhard BH; Travis LB
    J Pediatr; 1992 Apr; 120(4 Pt 1):541-5. PubMed ID: 1552391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for low bone mineral density in children and adolescents with inflammatory bowel disease.
    Lopes LH; Sdepanian VL; Szejnfeld VL; de Morais MB; Fagundes-Neto U
    Dig Dis Sci; 2008 Oct; 53(10):2746-53. PubMed ID: 18351466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone mineral density and bone acquisition in children and young adults with cystic fibrosis: a follow-up study.
    Ujhelyi R; Treszl A; Vásárhelyi B; Holics K; Tóth M; Arató A; Tulassay T; Tulassay Z; Szathmári M
    J Pediatr Gastroenterol Nutr; 2004 Apr; 38(4):401-6. PubMed ID: 15085018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison between spinal and radial bone mineral density in children measured by X-ray absorptiometry.
    Moreira-Andrés MN; Cañizo FJ; Papapietro K; Rejas J; Hawkins FG
    J Pediatr Endocrinol Metab; 1995; 8(1):35-41. PubMed ID: 7584695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Osteogenesis imperfecta: bone turnover, bone density, and ultrasound parameters.
    Cepollaro C; Gonnelli S; Pondrelli C; Montagnani A; Martini S; Bruni D; Gennari C
    Calcif Tissue Int; 1999 Aug; 65(2):129-32. PubMed ID: 10430645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis.
    Antoniazzi F; Bertoldo F; Mottes M; Valli M; Sirpresi S; Zamboni G; Valentini R; Tató L
    J Pediatr; 1996 Sep; 129(3):432-9. PubMed ID: 8804334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone mineral density in children with mild osteogenesis imperfecta.
    Zionts LE; Nash JP; Rude R; Ross T; Stott NS
    J Bone Joint Surg Br; 1995 Jan; 77(1):143-7. PubMed ID: 7822373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutations That Alter the Carboxy-Terminal-Propeptide Cleavage Site of the Chains of Type I Procollagen Are Associated With a Unique Osteogenesis Imperfecta Phenotype.
    Cundy T; Dray M; Delahunt J; Hald JD; Langdahl B; Li C; Szybowska M; Mohammed S; Duncan EL; McInerney-Leo AM; Wheeler PG; Roschger P; Klaushofer K; Rai J; Weis M; Eyre D; Schwarze U; Byers PH
    J Bone Miner Res; 2018 Jul; 33(7):1260-1271. PubMed ID: 29669177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study.
    Ward LM; Rauch F; Whyte MP; D'Astous J; Gates PE; Grogan D; Lester EL; McCall RE; Pressly TA; Sanders JO; Smith PA; Steiner RD; Sullivan E; Tyerman G; Smith-Wright DL; Verbruggen N; Heyden N; Lombardi A; Glorieux FH
    J Clin Endocrinol Metab; 2011 Feb; 96(2):355-64. PubMed ID: 21106710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome.
    Minetto M; Reimondo G; Osella G; Ventura M; Angeli A; Terzolo M
    Osteoporos Int; 2004 Nov; 15(11):855-61. PubMed ID: 15034643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth characteristics in individuals with osteogenesis imperfecta in North America: results from a multicenter study.
    Jain M; Tam A; Shapiro JR; Steiner RD; Smith PA; Bober MB; Hart T; Cuthbertson D; Krischer J; Mullins M; Bellur S; Byers PH; Pepin M; Durigova M; Glorieux FH; Rauch F; Lee B; Sutton VR; ; Nagamani SCS
    Genet Med; 2019 Feb; 21(2):275-283. PubMed ID: 29970925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of spontaneous calcium intake and physical exercise on the vertebral and femoral bone mineral density of children and adolescents.
    Ruiz JC; Mandel C; Garabedian M
    J Bone Miner Res; 1995 May; 10(5):675-82. PubMed ID: 7639101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A double-blind, randomized, Phase III, multicenter study in 358 pediatric subjects receiving isotretinoin therapy demonstrates no effect on pediatric bone mineral density.
    Hoover KB; Miller CG; Galante NC; Langman CB
    Osteoporos Int; 2015 Oct; 26(10):2441-7. PubMed ID: 25956286
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Corticosteroid exposure not associated with long-term bone mineral density in pediatric liver transplantation.
    Nightingale S; McEwan-Jackson FD; Hawker GA; Macarthur C; Khambalia AZ; Lo L; Fecteau A; Ng VL
    J Pediatr Gastroenterol Nutr; 2011 Sep; 53(3):326-32. PubMed ID: 21629126
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study.
    Otaify GA; Aglan MS; Ibrahim MM; Elnashar M; El Banna RA; Temtamy SA
    Osteoporos Int; 2016 Jan; 27(1):81-92. PubMed ID: 26138583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bone mineral content and density in healthy subjects and in osteogenesis imperfecta.
    Davie MW; Haddaway MJ
    Arch Dis Child; 1994 Apr; 70(4):331-4. PubMed ID: 8185368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.